£500K
The funding will support the implementation of specialised screening technology aimed at identifying rare diseases earlier in the patient journey.
Mendelian builds screening systems to help doctors identify rare and hard to diagnose conditions.
Mendelian is a healthtech startup based in London that builds screening systems to help clinicians identify patients with rare or hard to diagnose conditions. Its technology analyses medical records to flag potential cases early in the patient journey.

Peter Fish
Head of Clinical Partnerships
Peter serves as chief executive of Mendelian, following earlier roles as a co-founder of Tuune and CopperTable. He also advises the Wellcome Sanger Institute.
LinkedIn
The funding will support the implementation of specialised screening technology aimed at identifying rare diseases earlier in the patient journey.